The number of people with diabetes is increasing rapidly, making early detection and screening crucial in saving lives and preventing severe complications. Accurate blood glucose measurement is essential for successful screening and diagnosis of diabetes.
HemoCue® Glucose Systems are portable spectrophotometers designed for professional use, delivering lab-quality results with the convenience of point-of-care testing. These systems provide the accuracy needed for effective screening and aiding in the diagnosis of diabetes mellitus and gestational diabetes.
By combining HemoCue® Glucose Systems with other tests, such as HbA1c, you can create a comprehensive point-of-care testing portfolio for diabetes management. This integrated approach supports timely and accurate diagnosis, enhancing patient care and improving outcomes.
Explore our diabetes solutions and see how HemoCue can help you deliver reliable and efficient diabetes screening and diagnosis.
The HemoCue® Glucose 201 DM System is used in screening, monitoring and as an aid in the diagnosis of diabetes mellitus. With its unique microcuvette technology, the system provides the highest accuracy at the point of care while minimizing the risk of spreading infection. Plus, you have the added controls and productivity made possible with advanced data management.
The HemoCue® Glucose 201 System is an analyzer, not a meter. Unlike glucose strip meters, the HemoCue® Glucose 201 System can be used to support the clinical evidence in the diagnosis and treatment of diabetic patients.